Condition

Chronic Lymphocytic Leukemia (CLL) (2)

Diffuse Large B-cell Lymphoma (DLBCL) (2)

Follicular Lymphoma (FL) (2)

Mantle Cell Lymphoma (MCL) (2)

Small Lymphocytic Lymphoma (SLL) (2)

Acute Myeloid Leukemia (AML) (1)

High Grade Non-Hodgkin's Lymphoma (1)

Marginal Zone B Cell Lymphoma (1)

Marginal Zone Lymphoma (MZL) (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (2)

Sponsor

MEI Pharma, Inc. (2)

Collaborator

Intervention

me-401 (1)

rituximab (1)

voruciclib and venetoclax (1)

voruciclib monotherapy (1)

zanubrutinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

small lymphocytic lymphoma (sll)

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL) Trial in United States (voruciclib

Recruiting

Follicular Lymphoma (FL)
+6 more

voruciclib monotherapy
voruciclib and venetoclax

Duarte, California
+10 more

Aug 10, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

Recruiting

Chronic Lymphocytic Leukemia (CLL)
+6 more

ME-401
+2 more

Tucson, Arizona
+23 more

Dec 14, 2021